These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 36566303)

  • 1. Predictors of complete 24-month remission and flare in patients with polymyalgia rheumatica.
    Perricone C; Cafaro G; Fiumicelli E; Bursi R; Bogdanos D; Riccucci I; Gerli R; Bartoloni E
    Clin Exp Med; 2023 Nov; 23(7):3391-3397. PubMed ID: 36566303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sixth-month remission as a predictor for twelve-month remission in polymyalgia rheumatica.
    Birra D; Bosello SL; Peluso G; Zoli A
    Clin Exp Rheumatol; 2020; 38(3):436-441. PubMed ID: 31858957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tocilizumab vs placebo for the treatment of giant cell arteritis with polymyalgia rheumatica symptoms, cranial symptoms or both in a randomized trial.
    Spiera R; Unizony SH; Bao M; Luder Y; Han J; Pavlov A; Stone JH
    Semin Arthritis Rheum; 2021 Apr; 51(2):469-476. PubMed ID: 33784598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Tocilizumab on Disease Activity in Patients With Active Polymyalgia Rheumatica Receiving Glucocorticoid Therapy: A Randomized Clinical Trial.
    Devauchelle-Pensec V; Carvajal-Alegria G; Dernis E; Richez C; Truchetet ME; Wendling D; Toussirot E; Perdriger A; Gottenberg JE; Felten R; Fautrel BJ; Chiche L; Hilliquin P; Le Henaff C; Dervieux B; Direz G; Chary-Valckenaere I; Cornec D; Guellec D; Marhadour T; Nowak E; Saraux A
    JAMA; 2022 Sep; 328(11):1053-1062. PubMed ID: 36125471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymyalgia rheumatica and giant cell arteritis.
    Unwin B; Williams CM; Gilliland W
    Am Fam Physician; 2006 Nov; 74(9):1547-54. PubMed ID: 17111894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of remission is difficult due to frequent relapse during tapering steroids in Korean patients with polymyalgia rheumatica.
    Kim HA; Lee J; Ha YJ; Kim SH; Lee CH; Choi HJ; Baek HJ; Lim MJ; Park W; Choi S; Hong YS; Lee YH; Koh BR; Suh CH
    J Korean Med Sci; 2012 Jan; 27(1):22-6. PubMed ID: 22219609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating CD8+ T cells in polymyalgia rheumatica and giant cell arteritis: a review.
    Martinez-Taboada VM; Blanco R; Fito C; Pacheco MJ; Delgado-Rodriguez M; Rodriguez-Valverde V
    Semin Arthritis Rheum; 2001 Feb; 30(4):257-71. PubMed ID: 11182026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymyalgia rheumatica and giant cell arteritis.
    Healey LA; Wilske KR
    West J Med; 1984 Jul; 141(1):64-7. PubMed ID: 6475043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymyalgia rheumatica: clinical picture and principles of treatment.
    Zimmermann-Górska I
    Pol Arch Med Wewn; 2008 Jun; 118(6):377-80. PubMed ID: 18619195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical outcome of 149 patients with polymyalgia rheumatica and giant cell arteritis.
    Bahlas S; Ramos-Remus C; Davis P
    J Rheumatol; 1998 Jan; 25(1):99-104. PubMed ID: 9458211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of peripheral CD8 lymphocytes and soluble IL-2 receptor in predicting the duration of corticosteroid treatment in polymyalgia rheumatica and giant cell arteritis.
    Salvarani C; Boiardi L; Macchioni P; Rossi F; Tartoni P; Casadei Maldini M; Mancini R; Beltrandi E; Portioli I
    Ann Rheum Dis; 1995 Aug; 54(8):640-4. PubMed ID: 7677440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors for treatment success and expression of glucocorticoid receptor in giant cell arteritis and polymyalgia rheumatica.
    Braun N; Fritz P; Rieth A; Schroth W; Kimmel M; Biegger D; Zakim D; Alscher MD
    J Rheumatol; 2009 Oct; 36(10):2269-76. PubMed ID: 19684157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tocilizumab for the treatment of large-vessel vasculitis (giant cell arteritis, Takayasu arteritis) and polymyalgia rheumatica.
    Unizony S; Arias-Urdaneta L; Miloslavsky E; Arvikar S; Khosroshahi A; Keroack B; Stone JR; Stone JH
    Arthritis Care Res (Hoboken); 2012 Nov; 64(11):1720-9. PubMed ID: 22674883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymyalgia rheumatica and giant cell arteritis in older patients: diagnosis and pharmacological management.
    Schmidt J; Warrington KJ
    Drugs Aging; 2011 Aug; 28(8):651-66. PubMed ID: 21812500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can methotrexate be used as a steroid sparing agent in the treatment of polymyalgia rheumatica and giant cell arteritis?
    van der Veen MJ; Dinant HJ; van Booma-Frankfort C; van Albada-Kuipers GA; Bijlsma JW
    Ann Rheum Dis; 1996 Apr; 55(4):218-23. PubMed ID: 8733437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longterm therapy in polymyalgia rheumatica: effect of coexistent temporal arteritis.
    Narváez J; Nolla-Solé JM; Clavaguera MT; Valverde-García J; Roig-Escofet D
    J Rheumatol; 1999 Sep; 26(9):1945-52. PubMed ID: 10493675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of refractory polymyalgia rheumatica with etanercept: an open pilot study.
    Catanoso MG; Macchioni P; Boiardi L; Pipitone N; Salvarani C
    Arthritis Rheum; 2007 Dec; 57(8):1514-9. PubMed ID: 18050171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical characteristics and prognostic factors for relapse in patients with polymyalgia rheumatica (PMR).
    Lee JH; Choi ST; Kim JS; Yoon BY; Kwok SK; Kim HS; Kim YS; Song JS; Lee SH; Kim HR
    Rheumatol Int; 2013 Jun; 33(6):1475-80. PubMed ID: 23184033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies to cardiolipin and beta 2 glycoprotein I in patients with polymyalgia rheumatica and giant cell arteritis.
    Meyer O; Nicaise P; Moreau S; de Bandt M; Palazzo E; Hayem G; Chazerain P; Labarre C; Kahn MF
    Rev Rhum Engl Ed; 1996 Apr; 63(4):241-7. PubMed ID: 8738442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adrenal insufficiency in prednisolone-treated patients with polymyalgia rheumatica or giant cell arteritis-prevalence and clinical approach.
    Borresen SW; Thorgrimsen TB; Jensen B; Hilsted L; Bartels EM; Feldt-Rasmussen U; Locht H
    Rheumatology (Oxford); 2020 Oct; 59(10):2764-2773. PubMed ID: 32031663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.